ReviewMaterials (Basel, Switzerland)2026
MXene-Based Photocatalysts for Pharmaceutical Wastewater Remediation and Sustainable Energy Conversion: Mechanisms, Interface Engineering, and Future Perspectives.
Review in Materials (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Pharmaceutical residues in wastewater pose persistent ecological and public health risks, creating an urgent need for efficient and sustainable remediation technologies. MXene-based photocatalysts have attracted growing interest owing to their high electrical conductivity, tunable surface chemistry, abundant active sites, and excellent charge-transfer capability. This review summarizes recent advances in MXene-based photocatalytic systems for pharmaceutical wastewater treatment and renewable energy production. Key topics include pharmaceutical degradation pathways, reactive oxygen species generation, ecotoxicological implications, and the multifunctional roles of MXenes as conductive supports, electron mediators, and cocatalysts. Interfacial engineering strategies, including Z-scheme, S-scheme, and Schottky heterojunctions, are discussed with respect to light absorption, charge separation, and interfacial redox reactions. Practical considerations, such as reactor design, life cycle assessment, and techno-economic feasibility, are also addressed. Finally, current challenges and future directions are highlighted, particularly scalable fluorine-free synthesis, improved oxidative stability, and machine learning-assisted material design. This review provides a concise framework for developing stable, efficient, and scalable MXene-based photocatalytic platforms for pharmaceutical wastewater remediation and sustainable energy generation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.